State Street
ALMR icon

State Street’s Alamar Biosciences ALMR Stock Holding History

State Street’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.93M Buy
+145,059
New +$3.28M ﹤0.01% 3164

Other funds holding ALMR

Sands Capital Ventures
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
Samsara BioCapital
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Braidwell
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street's ALMR Position: Q2 2026 in Review

State Street opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 145,059 shares worth $3.93M. The stake represents ﹤0.01% of the portfolio and ranks #3164 among its holdings.

87 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

  • State Street held 145,059 shares of Alamar Biosciences worth $3.93M as of Q2 2026.
  • Alamar Biosciences was a new State Street position in Q2 2026.
  • Alamar Biosciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3164 holding.
  • 87 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.